Akemi Arakawa

An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies

Yafei Liu, Wai Tuck Soh, Jun-ichi Kishikawa et al. · Cell · 2021 · 285 citations · Full text

Vaccine Target, Viral Pathogenesis, Immunology +7

The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines

Yafei Liu, Noriko Arase, Jun-ichi Kishikawa et al. · 2021 · 38 citations

Vaccination, Future Vaccine Development, Complete Resistance +15

Genetic variability in swine leukocyte antigen class II and Toll-like receptors affects immune responses to vaccination for bacterial infections in pigs

Hiroki Shinkai, Akemi Arakawa, Maiko Tanaka-Matsuda et al. · Comparative Immunology Microbiology and Infectious Diseases · 2012 · 18 citations

Vaccination, Toll-like Receptors, Veterinary Vaccine +11

An infectivity-enhancing site on the SARS-CoV-2 spike protein is targeted by COVID-19 patient antibodies

Yafei Liu, Wai Tuck Soh, Asa Tada et al. · 2020 · 17 citations

Covid-19 Patient Antibodies, Vaccine Target, Viral Pathogenesis +12

Screening for 15 pathogenic viruses in human cell lines registered at the JCRB Cell Bank: characterization of <i>in vitro</i> human cells by viral infection

Setsuko Shioda, Fumio Kasai, Ken Watanabe et al. · Royal Society Open Science · 2018 · 16 citations · Full text